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Abstract
Background: Neutrophil cytosolic factor 1, p47phox (NCF1) is a component of the leukocyte
NADPH oxidase complex mediating formation of reactive oxygen intermediates (ROI) which play
an important role in host defense and autoimmunity. An individual genomic pattern of ncf1 and its
two types of pseudogenes (reflected by the ΔGT/GTGT ratio) may influence the individual capacity
to produce ROI.
Methods: NCF1ΔGT/GTGT ratios were correlated with clinical parameters and ROI production
during Plasmodium falciparum malaria and with susceptibility to the autoimmune disease multiple
sclerosis (MS).
Results: Among Gabonese children with severe malaria, ROI production from peripheral blood
tended to be higher in individuals with a ΔGT/GTGT ratio ≤ 1:1. ΔGT/GTGT ratios were not
associated with susceptibility to MS, but to age-of-onset among MS patients.
Conclusion: The genomic pattern of NCF1 and its pseudogenes might influence ROI production
but only marginally influence susceptibility to and outcome of malaria and MS.
Background
The release of reactive oxygen intermediates (ROI) consti-
tutes part of the innate immune responses against patho-
gens [1]. During malaria, ROI production can contribute
to both faster parasite clearance and more severe disease,
especially anaemia [2,3]. Furthermore, ROI are involved
in cell signalling pathways [4]. In autoimmune diseases
such as Multiple Sclerosis (MS), ROI have been implicated
as mediators for demyelination and axonal damage [5,6],
and enhanced respiratory burst activity has been detected
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uals [7].
One of the key enzymes leading to production of ROI is
the leukocyte NADPH oxidase, consisting of several subu-
nits, which are membrane-bound or located in the
cytosol. Loss-of-function-mutations within the genes of
these subunits lead to the development of chronic granu-
lomatous disease (CGD) [8]. Genetic variation in compo-
nents of the leukocyte NADPH oxidase may, therefore,
influence disease susceptibility to and disease course of
parasitic infection and autoimmune disease. The length of
a TA-repeat in the promoter region of the leukocyte
NADPH oxidase subunit gp91phox is associated with sever-
ity of malaria [9]. A single nucleotide polymorphism
(SNP) in the subunit neutrophil cytosolic factor (NCF) 4
(p40phox) has been shown to be associated with antibody-
negative arthritis [10]. Susceptibility to animal models of
autoimmune diseases such as collagen-induced arthritis
(CIA), experimental autoimmune neuritis (EAN) and
experimental autoimmune encephalomyelitis (EAE) is
influenced by genetic variation of Ncf1 (p47phox), another
NADPH-oxidase subunit [11,12]. An intrinsic lower ROI
release was associated with increased susceptibility to
arthritis in rats [13]. Recently it was shown that transgenic
expression of ncf1 in macrophages can suppress autoim-
mune T cell responses in mice [14].
A mutation in human NCF1 accounts for about 25% of all
CGD cases. Unlike the heterogeneous CGD-causing muta-
tions in other leukocyte NADPH oxidase subunits, about
95% of the cases are attributed to a NCF1 mutation carry
a common dinucleotide deletion (ΔGT) in exon 2, leading
to a frameshift and premature stop codon. This phenom-
enon is explained by the existence of two pseudogenes of
NCF-1 (ΨNCF1), located in the same genomic region on
chromosome 7q11.23 [8]. Two types of these pseudo-
genes have been described: type I ΨNCF1 contains the GT
deletion (ΔGT) while the more recently described type II
ΨNCF1 does not [15]. It is, therefore, possible that type II
ΨNCF1 might be translated into functional protein simi-
lar to the NCF1 gene. In healthy individuals (non-CGD,
non-carrier) the prevalence of type I and II ΨNCF1 can be
determined by the ΔGT/GTGT ratio. Heyworth et al found
among 53 healthy individuals 44 with a ratio of 2:1
(reflecting two type I ΨNCF1 genes per NCF1 gene), seven
with a ratio of 1:1 (reflecting heterozygosity for a haplo-
type containing each one type I and type II ΨNCF1) and
two with a ratio of 1:2 (possibly reflecting homozygosity
for a haplotype containing each one type I and type II
ΨNCF1) [15].
Whether the ΔGT/GTGT ratio has functional significance
in terms of individual NCF1 expression, ROI production
or susceptibility to infectious or autoimmune diseases is
currently unknown. This study evaluates whether NCF1
ΔGT/GTGT ratios are associated with severity of Plasmo-
dium falciparum malaria or individual ROI production in
Gabonese children suffering from malaria. In order to
search for a possible association with autoimmune dis-
eases, a case-control association study in MS patients from
Germany and Poland was conducted.
Methods
Patients
German MS patients (n = 265) were recruited at the Neu-
rology Department, University of Tübingen. German con-
trol persons (n = 191) were recruited from age and sex-
matched participants of the Dortmund Health Study, a
health survey of the general population in western Ger-
many. Polish MS patients (n = 187) were recruited at the
Department of Neurology, Medical University of Lodz.
Non-affected Polish persons (n = 184) served as regional
controls.
All patients were confirmed MS patients according to the
Poser or McDonald criteria [16,17].
Inclusion criteria and clinical parameters of Gabonese
children suffering from P. falciparum malaria have been
described previously [18,19]. Out of these patients, 86
children with severe malaria, defined by anaemia and
hyperparasitaemia, and 66 children with mild malaria
were analysed. Patients gave informed consent prior to
inclusion into the study and procedures were approved by
local ethic committees.
Measurements of ROI production
ROI production was measured in Gabonese children with
malaria [2,3]. Measurements were taken from whole
blood (diluted 1:100 in Krebs Ringer phosphate glucose
medium) and separated granulocyte suspensions with
and without stimulation using either the mitogen phor-
bol-12-myristate-13-acetate (PMA), the chemotactic pep-
tide N-formyl-methionyl-leucyl-phenylalanine (FMLP) or
tumour necrosis factor (TNF). Relative light units were
measured after adding 5-amino-2,3-dihydro-1,4-
phtalazin-dion (Luminol) to an concentration of 11 μM
in a luminometer (Lumat LB 9501-0 (Berthold AG, Wild-
bad, Germany) as described previously [2]. Measurements
were taken at admission into the study in all children. In
some of the children measurements were taken during
convalescence (approximately 1 month after inclusion)
and after six months, when they were in healthy condi-
tion.
ΔGT/GTGT ratios
ΔGT/GTGT ratios were measured as described previously
[20,21]. Briefly, exon 2 of the NCF1 gene/pseudogenes
was amplified from genomic DNA using the FAM-labeledPage 2 of 7
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and the unlabeled reverse primer 2RB2 5'-CTAAGGTCCT-
TCCCAAAGGGT-3' [15] under standard PCR conditions.
PCR products were quantified on a DNA sequencer using
the GENEMAPPER software v3.5 (both Applied Biosys-
tems, CA, USA). Individual ΔGT/GTGT ratios were calcu-
lated by dividing the area of the 209 bp peak (reflecting
PCR products from the genes carrying the ΔGT deletion)
by the area of the 211 bp peak (representing products
from the GTGT-containing sequence). Individuals can
have only discrete values of one or two ΔGT with one or
two GTGT genes per allele. Therefore, study persons were
categorized according to a cut-off value of 1.5 as having a
ratio ≤ 1:1 or ≥ 2:1. Measured median [interquartile range]
ratios from European individuals categorized as having a
ratio ≥ 2:1 were 2.28 [2.21 to 2.43] and for the ratio ≤ 1:1
were 1.09 [1.04 to 1.15]. Thus, actually measured ΔGT/
GTGT ratios were higher than the respective expected
ratios, most probably due to higher PCR efficacy of the
shorter ΔGT amplicon.
Statistics
Analysis of variance was performed in order to explain lev-
els of ROI production in children suffering from P. falci-
parum malaria by their ΔGT/GTGT ratios. The following
factors were included in the initial analysis: (1) severity of
malaria (mild versus severe, according to the inclusion cri-
teria), (2) ΔGT/GTGT ratio (≤ 1:1 versus ≥ 2:1), (3) time
point of measurement (admission, one month and six
months after admission), (4) all interactions between
these three factors, and (4) patient as a random factor
nested under severity. ROI data were log-transformed to
make normal distributions with equal variances plausible.
Consequently, geometric means, their ratios and 95%-
confidence intervals (CI) are given. P values were avoided,
as the case numbers were not planned for all the results in
this report. In the next step we searched for differences in
ROI production dependent of the ΔGT/GTGT ratio within
all subgroups defined by: (1) disease severity (mild versus
severe), (2) time point of measurement (admission, one
month and six months after admission) and (3) six differ-
ent stimulation conditions.
Analysis of variance was performed to explain MS severity
(defined by the EDSS) and age-of-onset with factors ΔGT/
GTGT ratio (≥ 2:1 versus ≤ 1:1) and disease course (bout-
onset versus progressive-onset). For statistical analysis the
JMP5 software package (SAS Institute, Cary, NC, USA) was
used. Meta-analysis for genetic association in German and
Polish populations was performed using the RevMan soft-
ware (Version 4.2 for Windows. Copenhagen: The Nordic
Cochrane Centre, The Cochrane Collaboration, 2003).
Results
Association of ΔGT/GTGT ratios with ROI production in 
Gabonese children
The initial analysis of variance of ROI production did not
establish a role for the ΔGT/GTGT ratio as a factor deter-
mining ROI production under any stimulation condition.
In the next step we searched for differences in ROI produc-
tion dependent of the ΔGT/GTGT ratios in different sub-
groups defined by severity of malaria, time point of
measurement and stimulation conditions. Only in the
group with severe malaria at admission a tendency for
higher maximum and cumulative ROI production by
unstimulated and stimulated peripheral blood mononu-
clear cells (PBMC) in children with a ratio ≤ 1:1 compared
to children with a ratio ≥ 2:1 was found. The geometric
mean of maximum and cumulative PMA-stimulated ROI
production within this subgroup was 1.7-fold higher in
children with a ΔGT/GTGT ratio ≤ 1:1 compared to chil-
dren with a ΔGT/GTGT ratio ≥ 2:1 (95% CI: 1.0 to 2.9 for
maximum and 1.0 to 3.0 for cumulative ROI production).
Maximum unstimulated ROI production was 1.9-fold
higher (95% CI: 0.8 to 3.7) in children with a ΔGT/GTGT
ratio ≤ 1:1 compared to children with a ΔGT/GTGT ratio ≥
2:1 (cumulative basal ROI production: 1.5-fold increase;
95% CI: 0.8 to 2.8). (Figure 1). This tendency for higher
ROI production in whole blood preparations from chil-
dren with a ΔGT/GTGT ratio ≤ 1:1 than from those with a
ratio ≥ 2:1 would be consistent with the previously pub-
lished observation, that individuals with ratio 1:2 had
about 76% more NCF-1 protein in their neutrophils com-
pared to persons having ratio 2:1 while one individual
with ratio 1:1 displayed an intermediate phenotype [8].
This finding would further support the hypothesis that
type II ΨNCF1 is translated into a p47phox protein.
Malaria disease course and ΔGT/GTGT ratios
In previous studies high ROI production from granulo-
cytes was associated with fast parasite clearance time in
the children with mild malaria [3]. On the other hand, in
children with severe malaria, a higher capacity to produce
ROI was associated to anaemia [2] demonstrating the
potential role of ROI for both parasite clearance and
mediating anaemia during Plasmodium falciparum infec-
tion. Therefore, ΔGT/GTGT ratios were correlated with the
clinical course of malaria. Frequencies of ΔGT/GTGT
ratios did not differ much between 86 children with
severe malaria (14/86 [16.3%] with ratio ≤ 1:1) and 66
children with mild malaria (13/66 [19.7%] with ratio ≤
1:1), the odds ratio (OR) being 0.79 (95% confidence
interval (CI) 0.34 to 1.84). There was a tendency for lower
haemoglobin (Hb) concentrations in children with a
ΔGT/GTGT ratio ≤ 1:1 (mean 8.9 g/dl) compared to chil-
dren with a ΔGT/GTGT ratio ≥ 2:1 (mean 9.4 g/dl; differ-
ence of mean -0.5 g/dl; 95% CI: -1.6 to 0.5 g/dl). These
data do not point towards a major role of ΔGT/GTGT ratioPage 3 of 7
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Maximum basal (left) and PMA-stimulated (right) ROI production in whole blood preparations of children suffering from severe m lariaFigure 1
Maximum basal (left) and PMA-stimulated (right) ROI production in whole blood preparations of children suf-
fering from severe malaria. Individuals with a ΔGT/GTGT ratio of 2:1 have two type I ΨNCF1 genes per NCF1 gene while 
individuals with a ratio of 1:1 or 1:2 have presumably one or more type II ΨNCF1 genes per NCF1 gene. Shown are log-trans-
formed maximum ROI levels measured during a 30-minute period, triangles represent individual data points, horizontal lines 




















Frequency of individuals with a ≤ 1:1 ΔGT/GTGT ratio among MS patients and control persons from Germany and Polandigur  2
Frequency of individuals with a ≤ 1:1 ΔGT/GTGT ratio among MS patients and control persons from Germany 
and Poland. The combined odds ratio for association of the ratio ≤ 1:1 with MS among German and Polish patients was cal-
culated using revman software (version 4.2 for Windows, Copenhagen: The Nordic Cochrane Centre, The Cochrane Collabo-
ration, 2003).
MS Control OR (fixed) Weight OR (fixed)
n/N n/N 95% CI % 95% CI
Germany             47/265                               28/191       60.87 1.26 [0.75, 2.09]        
Poland              19/187                               19/184       39.13 0.98 [0.50, 1.92]        
Total (95% CI) 452                                    375 100 1.15 [0.77, 1.72]
Test for heterogeneity: Chi² = 0.33, df = 1 (P = 0.57), I² = 0%
Test for overall effect: Z = 0.67 (P = 0.50)
0.2 0.5 1 2 5
Malaria Journal 2008, 7:251 http://www.malariajournal.com/content/7/1/251as a factor determining the disease course of Plasmodium
falciparum infection.
ΔGT/GTGT ratios and susceptibility to the autoimmune 
disease MS
As outlined above, there are data suggestive of a geneti-
cally determined role for oxidative burst during autoim-
mune diseases. Therefore, an association study of ΔGT/
GTGT ratio with the autoimmune disease MS was con-
ducted. Among 265 German MS patients, 47 (17.7%)
were found with a ratio ≤ 1:1 compared to 28/191
(14.7%) among control persons. In Polish MS patients
19/187 (10.2%) had a ratio ≤ 1:1 compared to 19/184
(10.3%) among control persons. A meta-analysis includ-
ing both populations did not show any significant associ-
ation (Figure 2).
Association of MS subphenotypes with ΔGT/GTGT ratios
Although general susceptibility to MS seems not to be
influenced by the ΔGT/GTGT ratio it might well be that it
constitutes a disease-modifying factor. ΔGT/GTGT ratios
were correlated with the MS sub-phenotypes: (1) disease-
severity and (2) age-of-onset. Detailed clinical data for
these analyses were available from 217 German MS
patients. Analysis of variance did not establish ΔGT/GTGT
ratio as a factor influencing disease severity (reflected by
Kurtzke's Expanded Disability Status Score [EDSS], an estab-
lished measurement score of disability in multiple sclero-
sis patients) but as a factor associated with age-of-onset
(whole model for age-of-onset: Rsquare 0.11, RMSE 8.9;
factor ΔGT/GTGT ratio P = 0.03; factor bout-onset versus
progressive-onset P < 0.001). Without adjustment for dis-
ease course (bout-onset versus progressive-onset) mean
age-of onset in patients with a ΔGT/GTGT ratio ≤ 1:1 was
32.2 years, in those with a ΔGT/GTGT ratio ≥ 2:1 was 29.3
years (mean difference 2.9 years, 95% CI -0.25 to 6.0
years). In the major subgroup of patients with bout dis-
ease onset mean age-of onset in patients with a ΔGT/
GTGT ratio ≤ 1:1 was 31.7 years, in those with a ΔGT/
GTGT ratio ≥ 2:1 was 28.4 years (mean difference 3.3
years, 95% CI 0.3 to 6.3 years, Figure 3). These findings
would fit the results from the animal models, in which a
defect in oxidative burst exacerbates disease [12]. In our
patients, a putative lower oxidative burst in individuals
with a ratio ≥ 2:1 would accordingly lead to an earlier dis-
ease onset in susceptible individuals.
Discussion
In this study the influence of ΔGT/GTGT ratio on two dis-
eases, a human parasitic infection and an autoimmune
disease affecting the central nervous system was investi-
gated. Only within the subgroup of children with severe
malaria during the acute disease, a weak association of
ΔGT/GTGT ratio with ROI production in whole blood was
found. It has been suggested that the ΔGT/GTGT ratio
influences the expression levels of NCF1 most probably
by the occurrence of an NCF1 transcript from the type II
pseudogene that does not contain the GT deletion, which
leads to a premature stop codon in the type I pseudogene
[8]. If this effect on p47phox expression in turn may deter-
mine oxidative burst is currently unclear. In cell lines from
persons hemizygous for the NCF1 locus decreased p47phox
expression and decreased superoxide anion production
has been observed [22]. The present data showing a ten-
dency for enhanced ROI production in individuals with a
ratio ≤ 1:1 would fit this hypothesis. However, no influ-
ence of ΔGT/GTGT ratios on clinical disease course of Plas-
modium falciparum malaria was detected, although it was
previously shown by us that ROI production plays a role
in parasite clearance as well as in the pathology of the dis-
ease [2,3].
Age-of-onset among German MS patients (bout onset only) with different ΔGT/GTGT ratiosFigure 3
Age-of-onset among German MS patients (bout 
onset only) with different ΔGT/GTGT ratios. Triangles 
represent individual data points of 41 MS patients with a 
ΔGT/GTGT ratio ≤ 1:1 and 161 MS patients with a ΔGT/
GTGT ratio ≥ 2:1, horizontal lines indicate means. For statis-
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two studies so far which examined the putative genetic
associations of p47phox pseudogenes and inflammatory
bowel disease (IBD). The initial publication showed a rel-
ative excess of ΔGT/GTGT ratio ≤ 1:1 in patients, espe-
cially in the subgroup of those with Crohn's disease [23].
A second study involving 488 IBD patients and 181 con-
trol persons did not reproduce these findings [21].
Genetic association of NCF1 with MS has so far been
reported only in animal models of the disease. In CIA and
EAE the presence of a genetic variant of ncf1 leads to
reduced oxidative burst and exacerbates disease [12]. In
the present study no association of ΔGT/GTGT ratios with
MS in a Polish and a German population was detected.
However, one limitation of this study is that only moder-
ate numbers of patients were included, which allows only
to exclude NCF1 ΔGT/GTGT ratios as a major susceptibil-
ity factor for MS. When searching for possible associations
with sub-phenotypes of MS, no influence of ΔGT/GTGT
ratios on MS disease severity was found. However, within
the German MS population ΔGT/GTGT ratios were associ-
ated with age-of-onset, namely that individuals with a
ratio ≤ 1:1 had a later disease onset. Assuming that a ΔGT/
GTGT ratio ≤ 1:1 would also be associated with higher
ROI production in MS patients, which in turn would
rather modulate T cell responses [14], these results do also
fit the findings in animal experiments.
Conclusion
This study examined for the first time a possible influence
of type I/type II NCF1 pseudogene ratios on ROI produc-
tion and disease severity in children with malaria and sus-
ceptibility to multiple sclerosis in a German and Polish
population. A tendency for higher ROI production among
persons with a ΔGT/GTGT ratio ≤ 1:1 compared to those
with a ratio of ≥ 2:1 only within a subgroup of children
with malaria was found. These results need to be con-
firmed in an independent set of patients focussing on the
acute phase of the disease. NCF1 ΔGT/GTGT ratios were
not associated with severity of malaria or susceptibility to
and severity of MS. However, an association with age-of-
onset among MS patients was detected. These results fit
the hypothesis that a ΔGT/GTGT ratio ≤ 1:1 could lead to
enhanced expression of NCF1 and subsequently to higher
ROI production which could in turn modulate T cell
responses. Based on these results, further studies involv-
ing larger numbers of clinically well-defined patients
would be needed in order to confirm this hypothesis.
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